PDGFRA and soft tissue sarcoma: In this regard during the writing of this manuscript, Olaratumab, a human IgG1 monoclonal antibody that binds to PDGFRα was approved by the FDA to be used in combination with doxorubicin for the treatment of adult patients with soft tissue sarcoma.